0001387131-18-002392.txt : 20180525 0001387131-18-002392.hdr.sgml : 20180525 20180525183104 ACCESSION NUMBER: 0001387131-18-002392 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180524 FILED AS OF DATE: 20180525 DATE AS OF CHANGE: 20180525 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cannon Louis A CENTRAL INDEX KEY: 0001700257 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37406 FILM NUMBER: 18862638 MAIL ADDRESS: STREET 1: 309 WAVERLEY OAKS ROAD, SUITE 105 CITY: WALTHAM STATE: ME ZIP: 02452 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Corindus Vascular Robotics, Inc. CENTRAL INDEX KEY: 0001528557 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 300687898 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 309 WAVERLEY OAKS ROAD STREET 2: SUITE 105 CITY: WALTHAM STATE: MA ZIP: 02452 BUSINESS PHONE: 508-653-3335 MAIL ADDRESS: STREET 1: 309 WAVERLEY OAKS ROAD STREET 2: SUITE 105 CITY: WALTHAM STATE: MA ZIP: 02452 FORMER COMPANY: FORMER CONFORMED NAME: Your Internet Defender, Inc DATE OF NAME CHANGE: 20110824 4 1 cannon-form4_052418.xml OWNERSHIP DOCUMENT X0306 4 2018-05-24 0 0001528557 Corindus Vascular Robotics, Inc. CVRS 0001700257 Cannon Louis A 309 WAVERLEY OAKS ROAD, SUITE 105 WALTHAM MA 02452 1 0 0 0 Common Stock 2018-05-24 4 P 0 10000 0.8009 A 82955 D Common Stock 2018-05-25 4 P 0 6500 0.7697 A 89455 D Common Stock 7557436 I See Footnote Includes 9,174 shares of common stock related to restricted stock units granted as part of the director's annual equity award in 2017 which provided for initial vesting of one-quarter of the granted units and subsequent quarterly vesting on December 22, 2017, March 22, 2018 and June 22, 2018, subject to the reporting person's continuous service with Corindus Vascular Robotics, Inc. through each such vesting date. 60,801 shares are held in Cardiac & Vascular Research Center 401k FBO Louis A. Cannon; the remaining shares are held directly. Consists of securities directly owned by BioStar Ventures III, L.P. Dr. Cannon is the founder and Senior Managing Director of BioStar Ventures III, L.P. and, as such, may be deemed to beneficially own the securities held of record by BioStar Ventures III, L.P. for purposes of Rule 16a-1(a). Dr. Cannon disclaims any beneficial ownership of the securities reported, except to the extent of any pecuniary interest therein. The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.8002 to $0.805, inclusive. The reporting person undertakes to provide to Corindus Vascular Robotics, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.7694 to $0.77, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. 67,301 shares are held in Cardiac & Vascular Research Center 401k FBO Louis A. Cannon; the remaining shares are held directly. /s/ Louis A. Cannon 2018-05-25